AbbVie is ending an eleven-year agreement with Alphabet’s Calico Labs, according to an internal email obtained by Stat News.
Critics, including some drugmakers, argue that new patent policies would make it more difficult for companies to bring ...
The alliance between AbbVie and Calico dates back to 2014, just a year after it was launched by Alphabet's Google unit, when ...
An 11-year, $2 billion partnership has yet to produce an approved drug, but five attempts are in clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback